Bayer Group cut its fiscal year 2023 outlook, mainly due to a significant further decline in sales of glyphosate-based products.
For full-year 2023, Bayer now anticipates sales to be between 48.5 billion euros and 49.5 billion euros on a currency-adjusted basis, i.e. based on the average monthly exchange rates in 2022. Previously, it expected sales of 51 billion euros to 52 billion euros.
EBITDA before special items is now expected to be in the range of 11.3 billion euros and 11.8 billion euros in 2023 on a currency-adjusted basis compared to the previous outlook of 12.5 billion euros to 13.0 billion euros.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.